186 related articles for article (PubMed ID: 2850434)
1. The effects of iron oxides on proton relaxivity.
Josephson L; Lewis J; Jacobs P; Hahn PF; Stark DD
Magn Reson Imaging; 1988; 6(6):647-53. PubMed ID: 2850434
[TBL] [Abstract][Full Text] [Related]
2. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
Jung CW; Jacobs P
Magn Reson Imaging; 1995; 13(5):661-74. PubMed ID: 8569441
[TBL] [Abstract][Full Text] [Related]
3. Ferrimagnetic susceptibility contrast agents.
Bach-Gansmo T
Acta Radiol Suppl; 1993; 387():1-30. PubMed ID: 8390776
[TBL] [Abstract][Full Text] [Related]
4. Crystal size and properties of superparamagnetic iron oxide (SPIO) particles.
Sjögren CE; Johansson C; Naevestad A; Sontum PC; Briley-Saebø K; Fahlvik AK
Magn Reson Imaging; 1997; 15(1):55-67. PubMed ID: 9084026
[TBL] [Abstract][Full Text] [Related]
5. Iron oxide nanosized clusters embedded in porous nanorods: a new colloidal design to enhance capabilities of MRI contrast agents.
Rebolledo AF; Laurent S; Calero M; Villanueva A; Knobel M; Marco JF; Tartaj P
ACS Nano; 2010 Apr; 4(4):2095-103. PubMed ID: 20355739
[TBL] [Abstract][Full Text] [Related]
6. Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite.
Gillis P; Koenig SH
Magn Reson Med; 1987 Oct; 5(4):323-45. PubMed ID: 2824967
[TBL] [Abstract][Full Text] [Related]
7. Magnetic characterization of iron oxides for magnetic resonance imaging.
Sjøgren CE; Briley-Saebø K; Hanson M; Johansson C
Magn Reson Med; 1994 Mar; 31(3):268-72. PubMed ID: 8057797
[TBL] [Abstract][Full Text] [Related]
8. [Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI].
Lucet I; Filmon R; Pouliquen D; Le Jeune JJ; Jallet P
Bull Assoc Anat (Nancy); 1994 Mar; 78(240):57-9. PubMed ID: 7519906
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.
Wang YX; Hussain SM; Krestin GP
Eur Radiol; 2001; 11(11):2319-31. PubMed ID: 11702180
[TBL] [Abstract][Full Text] [Related]
10. Relaxation behavior study of ultrasmall superparamagnetic iron oxide nanoparticles at ultralow and ultrahigh magnetic fields.
Wang W; Dong H; Pacheco V; Willbold D; Zhang Y; Offenhaeusser A; Hartmann R; Weirich TE; Ma P; Krause HJ; Gu Z
J Phys Chem B; 2011 Dec; 115(49):14789-93. PubMed ID: 21972868
[TBL] [Abstract][Full Text] [Related]
11. Ultrasmall mixed ferrite colloids as multidimensional magnetic resonance imaging, cell labeling, and cell sorting agents.
Groman EV; Bouchard JC; Reinhardt CP; Vaccaro DE
Bioconjug Chem; 2007; 18(6):1763-71. PubMed ID: 17941682
[TBL] [Abstract][Full Text] [Related]
12. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling.
Babic M; Horák D; Trchová M; Jendelová P; Glogarová K; Lesný P; Herynek V; Hájek M; Syková E
Bioconjug Chem; 2008 Mar; 19(3):740-50. PubMed ID: 18288791
[TBL] [Abstract][Full Text] [Related]
13. [Possibilities of using ferromagnetic materials for targeted drug transport].
Papisov MI; Samokhin GP; Smirnov MD; Torcholin VP; Smirnov VN
Biull Eksp Biol Med; 1984 Sep; 98(9):372-4. PubMed ID: 6207870
[TBL] [Abstract][Full Text] [Related]
14. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
15. [Preparation and characterization of superparamagnetic iron oxide nanoparticles].
Liu ST; Yan Y; Chen ZL; Zhang YZ; Jin X
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):331-4. PubMed ID: 16546740
[TBL] [Abstract][Full Text] [Related]
16. Relaxivity optimization of a PEGylated iron-oxide-based negative magnetic resonance contrast agent for T₂-weighted spin-echo imaging.
Pöselt E; Kloust H; Tromsdorf U; Janschel M; Hahn C; Maßlo C; Weller H
ACS Nano; 2012 Feb; 6(2):1619-24. PubMed ID: 22276942
[TBL] [Abstract][Full Text] [Related]
17. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
[TBL] [Abstract][Full Text] [Related]
18. Polyethyleneimine-mediated synthesis of superparamagnetic iron oxide nanoparticles with enhanced sensitivity in T2 magnetic resonance imaging.
Do MA; Yoon GJ; Yeum JH; Han M; Chang Y; Choi JH
Colloids Surf B Biointerfaces; 2014 Oct; 122():752-759. PubMed ID: 25194592
[TBL] [Abstract][Full Text] [Related]
19. Soluble paramagnetic chelates and stabilized colloidal particle solutions of iron oxides as contrast agents for magnetic resonance imaging.
Tombach B; Reimer P
Curr Med Chem; 2005; 12(23):2795-804. PubMed ID: 16305473
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRI.
Pouliquen D; Perroud H; Calza F; Jallet P; Le Jeune JJ
Magn Reson Med; 1992 Mar; 24(1):75-84. PubMed ID: 1556931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
